Central nervous system relapse after combination therapy including polatuzumab vedotin in patients with diffuse large

Yoshikazu Hori1, Hiroki Hosoi1, Toshiki Mushino1

  • 1Department of Hematology/Oncology, Wakayama Medical University, Wakayama, Japan.

PubMed

Related Concept Videos